Jeanne M. Regnante

Statistics

Publications

Citations

376

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Fox Chase Cancer Center

United States Food and Drug Administration

University of California, Davis

Johnson & Johnson (United States)

Jeanne M. Regnante is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in cancer health disparities, medicine, and clinical trials.

ORCID

Publications per year

2015–2021

Publications

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action

Anton Hoos, James W. Anderson, Marc Boutin et al. · Therapeutic Innovation & Regulatory Science · 2015 · 203 citations · Full text

Medicine, Pharmacoeconomics, Clinical Pharmacology +11

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials

Jeanne M. Regnante, Nicole Richie, Lola A. Fashoyin‐Aje et al. · Journal of Oncology Practice · 2019 · 92 citations · Full text

Medicine, Oncology, Cancer Control +16

Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations

Karen M. Winkfield, Jeanne M. Regnante, Ellen Miller‐Sonet et al. · JCO Oncology Practice · 2021 · 44 citations · Full text

Public Health, Health Policy, Oncology +16

Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials

Jeanne M. Regnante, Nicole Richie, Lola A. Fashoyin‐Aje et al. · Contemporary Clinical Trials Communications · 2020 · 37 citations · Full text

Medicine, Oncology, Clinical Data Management +14

1–4 of 4